TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
CBUS

Cibus Global LLC

Healthcare · Biotechnology

1.50$ -3.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CBUS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
96.3% 32.9% 79.6% 80.4% 72.1% 62.5% 40.8% 18.4% 6.5% 4.8% 4.0%
95.0% 30.2% 78.5% 79.0% 66.5% 27.3% 37.2% 15.3% 6.0% 4.1% 3.3%
95.0% 30.2% 78.5% 79.0% 66.5% 45.8% 37.2% 15.3% 6.0% 4.1% 3.3%
1.3% 0.9% 0.2% 0.0% 1.3% 7.7% 0.0% 0.0% 0.1% 0.3% 0.2%
4.8% 1.7% 1.1% 2.9% 2.2% 0.0%
25.9% 5.7% 26.3% 36.1% 58.4% 80.9%
0.0% 79.9% 72.4% 76.2%
0.7% 6.5% 9.6% 10.4%
6.7% 21.1% 20.4% 21.4% 29.0% 41.8% 62.0% 67.7% 37.9% 72.1% 92.8%
4.0% 17.2% 5.9% 5.9% 8.2% 11.0% 13.1% 7.4% 3.9% 5.7% 5.5%
1.9% 0.2% 0.4% 0.6% 1.0% 2.1% 1.3% 0.1% 1.0%
1.2% 2.1% 1.4% 0.7% 1.2% 1.5% 3.4% 1.5% 1.1% 1.7% 2.6%
3.1% 0.3% 2.4% 0.1% 0.1% 0.0%
93.3% 78.9% 79.6% 78.6% 71.0% 58.2% 38.0% 32.3% 62.1% 27.9% 7.2%
-63.4% -171.9% -75.6% -69.4% -138.5% -263.5% -527.2% -946.2% -88.1% -208.9% -281.4%
40.9% 64.0% 12.8% 10.3% 14.9% 21.4% 31.1% 51.6% 1.9% 6.6% 15.0%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?